Cake sales going well Alex Tonks 😋 👌

1st cake sale in full swing , one of the lovely ladies bought each one of the chemotherapy patients one each.Any donations would be so appreciated 🤗 Cure Leukaemia
justgiving.com/page/crg

#Hematology Comparison of #CARTcell vs. bispecific antibody as third- or later-line large B-cell #lymphoma #DLBCL therapy: A Meta-analysis | ⁦Blood Journal⁩ | American Society of Hematology ⁦ASH⁩ #lymsm ashpublications.org/blood/article/…

Thanks so much Just Love for your generous donation for our cake sale next week Cure Leukaemia 🙌
justgiving.com/page/crg

Fantastic experience that I highly recommend 👌

📢Our latest IACH for Nurses:
Management of patients receiving antiCD38 (supporting tools on how to manage them, AEs)

📽️Now available on demand
Watch the full library for FREE
🔽🔽
clinical-hematology.org/iach-for-nurse…

Emma Williams Mohamad Mohty

Just out: International Myeloma Working Group guidelines for bispecific antibodies myeloma.

Limited time: Free copy link in the thread. The Lancet Oncology Paula Rodriguez-Otero Jonathan Kaufman, MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Yi Lin Tom Martin marivi mateos Ben Derman Monique Minnema et al thelancet.com/journals/lanon…

Fantastic session on mentorship and a safe space to discuss issues.Didact team we are so grateful for such a fantastic opportunity 🙌 Accelerating Clinical Trials

Just rehearsing our slides prior to the Dragons Den and this resonated after the PPI session.Patients views are crucial and should be at the very heart of any research project 👇

Fab, best of luck Beth 👍

PPI session kicks off, fantastic discussions Accelerating Clinical Trials Leukaemia UK

One of the best 👌

Job Alert! We have a 3yr post doc job available in my lab at the UCL Cancer Institute London UCL Cancer Institute UCL Cancer Domain ECN funded by Cancer Research UK looking at how noncoding mutations form oncogenic enhancers in T-ALL. nature.com/naturecareers/…

UK real world data Glofitamab
Kush Ediri

n=74, 17 centres 2023-2024
🔹Short fu (median 4m) but outcomes⬇️ cf trial data
🔹Median 3 prior lines, 65% 4th line
🔹CRS 32%
🔸CMR 25% ORR 46%
🔹Real world: PS diverse, histology incl, higher risk genomic profile

BSH - Haematology #BSH24

Today we’ve published our new report: Improving Young People’s Access to Cancer Clinical Trials 📝

This report warns that too many young people with cancer are missing out on the chance to take part in innovative clinical trials which could increase their chances of survival.

🌟 It's a proud moment for the Tonks/Darley AML research group to present AML ongoing research projects at the BSH2024. Professor Alex Tonks hard work and dedication have led to this achievement, and we're excited to showcase the impactful research you've been conducting.

We just caught up with Mary Frances McMullin from Queen's University, who gave an insight into the management of #Myelofibrosis in patients w/ anemia, the current BSH guidelines for diagnosis & evaluation of prognosis of the disease, & more!

#BSH2024 #HemOnc #MPNsm BSH - Haematology

Still time to apply...Fab opportunity 👀

Delighted to be part of a BSH - Haematology We are NIHR session on the value of #ahp research in haematology with @haemdietician - a small group that wants to get bigger! #BSH2024 Orla McCourt HCPA

Still so much left to do... 🙁